Study of Nitazoxanide in the Treatment of Amebiasis in Children

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Amebiasis

See also
Status	Clinical Trial	Phase
Terminated	`NCT00001162` - Parasitic Infections of the Gastrointestinal Tract	N/A
Completed	`NCT02734264` - Field Studies of Amebiasis in Bangladesh	N/A
Completed	`NCT00366236` - Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents	Phase 3

See also

Status

Clinical Trial

Phase

Terminated

NCT00001162 - Parasitic Infections of the Gastrointestinal Tract

N/A

Completed

NCT02734264 - Field Studies of Amebiasis in Bangladesh

N/A

Completed

NCT00366236 - Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00366730
Study type	Interventional
Source	Romark Laboratories L.C.
Contact
Status	Completed
Phase	Phase 3
Start date	February 2004
Completion date	November 2005

Study of Nitazoxanide in the Treatment of Amebiasis in Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms